(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.
MRI Treat-to-Target Strategy Fails to Help RA Patients Reach Remission
Emerging Agents in the Treatment of Rheumatic Diseases
International Working Group Releases First Guideline for Osteoporosis in Men
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
Febuxostat Use Among Gout Asian Patients Linked to Increased Cardiovascular Risk
Early-Onset IBD Linked to Greater Risk of Diseases with Possible Autoimmune Pathogenesis